Abstract
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) is an aggressive primary cutaneous B-cell lymphoma affecting older people.1 Rituximab (RTX) combined with polychemotherapy (RTX-PCT) has improved survival but relapses are frequent.2 Central nervous system (CNS) involvement is rare and poorly described.
This article is protected by copyright. All rights reserved.
http://ift.tt/2rdw0qz
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου